Janssen Search
Search results
Janssen Provides Portfolio Update
Mar 29, 2023 United States RARITAN, N.J., March 29, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson disclosed today that following a review of its portfolio to prioritize the most transformational assets for ongoing investment, and an ...
Janssen Showcases Support for Patients This World Lupus Day
Supporting Patients on World Lupus Day and Every Day On May 10, we recognize World Lupus Day by remaining committed to deepening our understanding of lupus, a complex and often misdiagnosed disease affecting more than five million people worldwide. ...
Our Research & Development Locations
Article Type: Research & Development Research & Development Locations Janssen Research & Development and Janssen Affiliate Locations Belgium Beerse Turnhoutseweg 30 2340 Beerse, Belgium Ontario, Canada Toronto 19 Green Belt Drive Toronto, ...
Peter M. DiBattiste, M.D.
Peter M. DiBattiste, M.D. is responsible for co-leading the Cardiovascular & Metabolism (CVM) Therapeutic Area at Janssen Research & Development, setting the strategy and leading the team in discovery and development of novel therapeutics for ...
Neely Mozaffarian, M.D., Ph.D.
NEELY MOZAFFARIAN, M.D., PH.D. VICE PRESIDENT AUTOANTIBODY PATHWAY AREA LEADER IMMUNOLOGY Neely Mozaffarian, M.D., Ph.D., is Vice President, Autoantibody Pathway Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. ...
The Mission That Binds Us
The Mission That Binds Us Those of us who work in drug development, we don’t all have the same journey to our profession. Some of us were brilliant at math and science, some desired to be challenged daily and others wanted to bring our creativity into ...
Wayne Drevets, M.D.
WAYNE DREVETS, M.D. DISEASE AREA LEADER, NEUROPSYCHIATRY Wayne Drevets, M.D. is Stronghold Leader, Neuropsychiatry Disease Area for Neuroscience, where he leads a cross-functional team in the development of Janssen's industry-leading portfolio of ...
Teaming up to Defeat Multiple Myeloma
Teaming up to Defeat Multiple Myeloma A molecular view of the CAR-T therapy at work. The early data results seemed almost too good to be true. That's what Sen Zhuang, M.D., Ph.D., Vice President, Oncology Clinical Research, Janssen Research & ...
Gene Expression & Skin Clearing in Psoriasis
Gene Expression & Skin Clearing in Psoriasis Understanding the intricacies of psoriasis and how therapies act on the disease can help to inform clinicians and their patients as they seek to make important treatment decisions. As I participate this ...
Contact Us – Oncology
Contact Oncology at Janssen Apr 02, 2015 Thank you for your interest in learning more about our company. Interested in a potential collaboration with Janssen? Contact us with your idea. If you are a member of the media, and need to reach our Research & ...